Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Jul 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special program that uses vibrations on the muscles of stroke patients who are in the subacute phase of recovery, which is about 14 days to 3 months after a stroke. The goal is to see if adding these vibration sessions to standard rehabilitation can help improve walking speed and overall movement. Participants will be divided into two groups: one will receive real vibrations, while the other will receive sham (or fake) vibrations, allowing researchers to compare the results.

To be eligible for this study, participants must be adults who have had their first stroke and are experiencing some weakness in their lower limbs. They should not have any other serious neurological conditions and must be able to give consent to participate. Those who join the trial can expect to take part in rehabilitation sessions that include either the vibration treatment or the sham treatment, helping researchers understand if vibrations truly make a difference in recovery. It's important to know that this trial is currently recruiting participants of all genders within the age range of 65 to 75 years.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke)
• • First hemispheric, ischemic or hemorrhagic stroke
• • Lower-limb deficiency with an initial motor testing \< 4 according to the MRC scale
• • No neurological history with functional impact other than stroke
• • Having received informed information about the study and having signed the written consent
• • Affiliated or entitled to a social security scheme.
• Exclusion Criteria:
• • Multiple stroke
• • Other neurological, cognitive or psychiatric conditions
• • Orthopedic ankle history compromising measurements
• • Botulinum toxin injected in the lower limb prior the study protocol
• • Patient with a skin lesion close to the site for the placement of the stimulator
• • Patient under tutorship or curatorship